Differentitation between Primary Central Nervous System Lymphoma and Glioblastoma: Added Value of Quantitative Analysis of CT Attenuation and Apparent Diffusion Coefficient
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose : Purpose of this study was to determine if quantitative measures of CT attenuation and ADC values in combination with conventional imaging features can differentiate primary central nervous system lymphoma (PCNSL) and glioblastoma (GBM). Materials and Methods: Twenty-six patients with histologically-proven GBM (14 men and 12 women; median age, 50years; age range, 22 - 73 years) and 14 patients with PCNSL (11 men and 3 women; median age, 61 years; age range, 41- 74 years) were enrolled. Maximum CT attenuation, minimum ADC, and lesion to normal parenchyma minimum ADC ratios were measured in solid tumor regions. Conventional imaging features were evaluated for the following: ill-defined margin, homogeneous enhancement pattern, degree of necrosis, extent of tumor involvement and multiplicity. The Mann-Whitney test was used to compare maximum CT attenuation and minimum ADC values for PCNSL and GBM. Fisher’s exact test was used to evaluate relationships between pathologic diagnoses and imaging features. Results: The CT attenuations were similar for PCNSL and GBM (37.84 ± 6.90 HU versus 37.00 ± 5.54 HU, p = 0.68), but minimum ADC and minimum ADC ratio were significant lower in PCNSL than in GBM (595.01 ± 228.2810-6 mm2/s versus 736.52 ± 162.05 10-6 mm2/s; p = 0.028, 0.87 ± 0.26 versus 1.14 ± 0.29; p = 0.007). PCNSL showed greater homogeneous enhancement and smaller necrotic areas than GBM (p = 0.003 and p < 0.001, respectively) and was more likely to have multiple tumors than GBM (p = 0.039). When necrotic PCNSL (n = 4) and necrotic GBM (n = 24)were compared, minimum ADC and minimum ADC ratios were also significantly lower in PCNSL, but CT attenuation were not. Conclusion: Although CT attenuation does not provide valuable information, minimum ADC and minimum ADC ratio and some imaging features can aid the differentiation of PCNSL and GBM.
Abstract
Purpose : Purpose of this study was to determine if quantitative measures of CT attenuation and ADC values in combination with conventional imaging features can differentiate primary central nervous system lymphoma (PCNSL) and glioblastoma (GBM). Materials and Methods: Twenty-six patients with histologically-proven GBM (14 men and 12 women; median age, 50years; age range, 22 - 73 years) and 14 patients with PCNSL (11 men and 3 women; median age, 61 years; age range, 41- 74 years) were enrolled. Maximum CT attenuation, minimum ADC, and lesion to normal parenchyma minimum ADC ratios were measured in solid tumor regions. Conventional imaging features were evaluated for the following: ill-defined margin, homogeneous enhancement pattern, degree of necrosis, extent of tumor involvement and multiplicity. The Mann-Whitney test was used to compare maximum CT attenuation and minimum ADC values for PCNSL and GBM. Fisher’s exact test was used to evaluate relationships between pathologic diagnoses and imaging features. Results: The CT attenuations were similar for PCNSL and GBM (37.84 ± 6.90 HU versus 37.00 ± 5.54 HU, p = 0.68), but minimum ADC and minimum ADC ratio were significant lower in PCNSL than in GBM (595.01 ± 228.2810-6 mm2/s versus 736.52 ± 162.05 10-6 mm2/s; p = 0.028, 0.87 ± 0.26 versus 1.14 ± 0.29; p = 0.007). PCNSL showed greater homogeneous enhancement and smaller necrotic areas than GBM (p = 0.003 and p < 0.001, respectively) and was more likely to have multiple tumors than GBM (p = 0.039). When necrotic PCNSL (n = 4) and necrotic GBM (n = 24)were compared, minimum ADC and minimum ADC ratios were also significantly lower in PCNSL, but CT attenuation were not. Conclusion: Although CT attenuation does not provide valuable information, minimum ADC and minimum ADC ratio and some imaging features can aid the differentiation of PCNSL and GBM.
참고문헌 (31)
- Haldorsen IS, "Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey", Cancer, 110, pp.1803~1814 (2007)
- Haldorsen IS, "Central nervous system lymphoma: characteristic findings on traditional and advanced imaging", AJNR Am J Neuroradiol, 32, pp.984~992 (2011)
- Shah GD, "Treatment of primary central nervous system lymphoma", Hematol Oncol Clin North Am, 19, pp.611~627 (2005)
- O’Brien PC, "Combined-modality therapy for primary central nervous system lymphoma: longterm data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group)", Int J Radiat Oncol Biol Phys, 64, pp.408~413 (2006)
- Elder JB, "Surgical interventions for primary central nervous system lymphoma", Neurosurg Focus, 21, pp.13~ (2006)
- Stupp R, "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma", N Engl J Med, 352, pp.987~996 (2005)
- Pichlmeier U, "Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients", Neuro Oncol, 10, pp.1025~1034 (2008)
- Stummer W, "Cytoreductivesurgery of glioblastoma as the key to successful adjuvanttherapies: new arguments in an old discussion", Acta Neurochir(Wien), 153, pp.1211~1218 (2011)
- Koeller KK, "Primary central nervous system lymphoma: radiologic-pathologic correlation", Radiographics, 17, pp.1497~1526 (1997)
- Coulon A, "Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients", Eur Radiol, 12, pp.329~340 (2002)
- Go JL, "Imaging of primary central nervous system lymphoma", Neurosurg Focus, 21, pp.4~ (2006)
- Hartmann M, "Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging", Neurosci Lett, 338, pp.119~122 (2003)
- Cianfoni A, "Brain perfusion CT: principles, technique and clinical applications", Radiol Med, 112, pp.1225~1243 (2007)
- Zacharia TT, "Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy", J Neuroimaging, 18, pp.411~417 (2008)
- Stadnik TW, "Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings", AJNR Am J Neuroradiol, 22, pp.969~976 (2001)
- Toh CH, "Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging", AJNR Am J Neuroradiol, 29, pp.471~475 (2008)
- 문원진, "Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging", NEURORADIOLOGY, 54(6), pp.555~563, SPRINGER
- Kim DS, "Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging", RADIOLOGY, 251(2), pp.467~475, RADIOLOGICAL SOC NORTH AMERICA
- Parizel PM, "Intracranial hemorrhage: principles of CT and MRI interpretation", Eur Radiol, 11, pp.1770~1783 (2001)
- Erdag N, "Primary lymphoma of the central nervous system: typical and atypical CT and MR imaging appearances", AJR Am J Roentgenol, 176, pp.1319~1326 (2001)
- Guo AC, "Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics", Radiology, 224, pp.177~183 (2002)
- Horger M, "Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum", AJR Am J Roentgenol, 193, pp.1384~1387 (2009)
- Sasaki M, "Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study", Radiology, 249, pp.624~630 (2008)
- Haldorsen IS, "CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003", AJNR Am J Neuroradiol, 30, pp.744~751 (2009)
- Kuker W, "Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients", J Neurooncol, 72, pp.169~177 (2005)
- Hayakawa T, "Primary central nervous system lymphoma in Japan--a retrospective, cooperative study by CNS-Lymphoma Study Group in Japan", J Neurooncol, 19, pp.197~215 (1994)
- Slone HW, "CT and MRI findings of intracranial lymphoma", AJR Am J Roentgenol, 184, pp.1679~1685 (2005)
- Barami K, "Relationship of gliomas to the ventricular walls", J Clin Neurosci, 16, pp.195~201 (2009)
- Lim DA, "Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype", Neuro Oncol, 9, pp.424~429 (2007)
- Buhring U, "MRI features of primary central nervous system lymphomas at presentation", Neurology, 57, pp.393~396 (2001)
- Fine HA, "Primary central nervous system lymphoma", Ann Intern Med, 119, pp.1093~1104 (1993)